Recent research has demonstrated that cytoplasmic HMGB1 can exacerbate inflammation-associated cellular injury by activating renal tubular ferroptosis following I/R injury, highlighting HMGB1 as a promising therapeutic target for acute kidney injury (AKI) [22]. The gene discussed is HMGB1; the disease is acute kidney injury.